» Articles » PMID: 15776110

Deletion of IKK2 in Hepatocytes Does Not Sensitize These Cells to TNF-induced Apoptosis but Protects from Ischemia/reperfusion Injury

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2005 Mar 19
PMID 15776110
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

The inhibitor of NF-kappaB (I-kappaB) kinase (IKK) complex consists of 3 subunits, IKK1, IKK2, and NF-kappaB essential modulator (NEMO), and is involved in the activation of NF-kappaB by various stimuli. IKK2 or NEMO constitutive knockout mice die during embryogenesis as a result of massive hepatic apoptosis. Therefore, we examined the role of IKK2 in TNF-induced apoptosis and ischemia/reperfusion (I/R) injury in the liver by using conditional knockout mice. Hepatocyte-specific ablation of IKK2 did not lead to impaired activation of NF-kappaB or increased apoptosis after TNF-alpha stimulation whereas conditional NEMO knockout resulted in complete block of NF-kappaB activation and massive hepatocyte apoptosis. In a model of partial hepatic I/R injury, mice lacking IKK2 in hepatocytes displayed significantly reduced liver necrosis and inflammation than wild-type mice. AS602868, a novel chemical inhibitor of IKK2, protected mice from liver injury due to I/R without sensitizing them toward TNF-induced apoptosis and could therefore emerge as a new pharmacological therapy for liver resection, hemorrhagic shock, or transplantation surgery.

Citing Articles

DA-6034 ameliorates hepatic steatosis and inflammation in high fat diet-induced obese mice.

Kim H, Kwon M, Lee E, Ha K, Chung C J Yeungnam Med Sci. 2024; 41(2):103-112.

PMID: 38486464 PMC: 11074837. DOI: 10.12701/jyms.2023.01389.


Implications of neonatal absence of innate immune mediated NFκB/AP1 signaling in the murine liver.

Grayck M, McCarthy W, Solar M, Balasubramaniyan N, Zheng L, Orlicky D Pediatr Res. 2024; 95(7):1791-1802.

PMID: 38396130 DOI: 10.1038/s41390-024-03071-0.


Current investigations for liver fibrosis treatment: between repurposing the FDA-approved drugs and the other emerging approaches.

Mohammed O, Attia H, Mohamed B, Elbaset M, Fayed H J Pharm Pharm Sci. 2023; 26:11808.

PMID: 38022905 PMC: 10662312. DOI: 10.3389/jpps.2023.11808.


Molecular Mechanisms of Ischaemia-Reperfusion Injury and Regeneration in the Liver-Shock and Surgery-Associated Changes.

Pretzsch E, Niess H, Ben Khaled N, Bosch F, Guba M, Werner J Int J Mol Sci. 2022; 23(21).

PMID: 36361725 PMC: 9657004. DOI: 10.3390/ijms232112942.


Effects of iNOS in Hepatic Warm Ischaemia and Reperfusion Models in Mice and Rats: A Systematic Review and Meta-Analysis.

Nakatake R, Schulz M, Kalvelage C, Benstoem C, Tolba R Int J Mol Sci. 2022; 23(19).

PMID: 36233220 PMC: 9569681. DOI: 10.3390/ijms231911916.


References
1.
Mercurio F, Zhu H, Murray B, Shevchenko A, Bennett B, Li J . IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science. 1997; 278(5339):860-6. DOI: 10.1126/science.278.5339.860. View

2.
Zandi E, Rothwarf D, Delhase M, Hayakawa M, Karin M . The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell. 1997; 91(2):243-52. DOI: 10.1016/s0092-8674(00)80406-7. View

3.
Trautwein C, Rakemann T, Brenner D, Streetz K, Licato L, Manns M . Concanavalin A-induced liver cell damage: activation of intracellular pathways triggered by tumor necrosis factor in mice. Gastroenterology. 1998; 114(5):1035-45. DOI: 10.1016/s0016-5085(98)70324-5. View

4.
Zwacka R, Zhou W, Zhang Y, Darby C, Dudus L, Halldorson J . Redox gene therapy for ischemia/reperfusion injury of the liver reduces AP1 and NF-kappaB activation. Nat Med. 1998; 4(6):698-704. DOI: 10.1038/nm0698-698. View

5.
Yamaoka S, Courtois G, Bessia C, Whiteside S, Weil R, Agou F . Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell. 1998; 93(7):1231-40. DOI: 10.1016/s0092-8674(00)81466-x. View